Cargando…
Therapeutic potential of human serum albumin nanoparticles encapsulated actinonin in murine model of lung adenocarcinoma
Non-small cell lung cancer comprises 85% of the global lung cancer cases. Conventional chemotherapeutics possess certain limitations like systemic toxicity and drug resistance that requires the development of new therapeutic agents for successful treatment of lung cancer. Actinonin, a human peptide...
Autores principales: | Ahlawat, Priyanca, Phutela, Kanika, Bal, Amanjit, Singh, Navneet, Sharma, Sadhna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336490/ https://www.ncbi.nlm.nih.gov/pubmed/35892161 http://dx.doi.org/10.1080/10717544.2022.2067600 |
Ejemplares similares
-
Fluorescent Phthalocyanine-Encapsulated Bovine Serum Albumin Nanoparticles: Their Deployment as Therapeutic Agents in the NIR Region
por: Borlan, Raluca, et al.
Publicado: (2021) -
Aminopeptidase inhibitors bestatin and actinonin inhibit cell proliferation of myeloma cells predominantly by intracellular interactions
por: Grujić, Mirjana, et al.
Publicado: (2002) -
A single point mutation in the Plasmodium falciparum FtsH1 metalloprotease confers actinonin resistance
por: Goodman, Christopher D, et al.
Publicado: (2020) -
“Cannon-Ball” skin metastases as the presenting manifestation of lung adenocarcinoma
por: Maji, Saurabh, et al.
Publicado: (2017) -
The Inhibition and Resistance Mechanisms of Actinonin, Isolated from Marine Streptomyces sp. NHF165, against Vibrio anguillarum
por: Yang, Na, et al.
Publicado: (2016)